This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Dr Gabriel Markson, PhD
Co-founder & Managing Partner
Instrumental in EUR >15 Billion of realized Private Equity transaction value over the course of his career.
Expert in identifying, acquiring, and exiting Life Sciences companies, assets, and technologies set for greatness.
Life Sciences entrepreneur and M&A practitioner focused on buying and improving European Life Sciences investments, including those backed by one of the world’s largest financial investors. Operational Management of portfolio companies of Nordic Capital, EQT, and Investor, focused on driving strategy, corporate development, operational transformations, and exits.
Molecular Biologist at the Cambridge Institute for Medical Research (CIMR), PhD in Molecular and Cell Biology from University of Cambridge; BSc Hons in Biological Sciences with Honours in Genetics from The University of Edinburgh.